Evidence map›Paper›PMID 36814227›Full record

ArticleBMC endocrine disorders2023

Feto-placental endothelial dysfunction in Gestational Diabetes Mellitus under dietary or insulin therapy.

Jing-Jing Wang, Xi Wang, Qian Li, Hua Huang, Qiao-Ling Zheng, Qin Yao, Jun Zhang

Open access · goldAbstract read
In one paragraph

Article in BMC endocrine disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Cellular and Molecular Pathophysiology of Gestational Diabetes.International journal of molecular sciences · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jing-Jing WangDepartment of Clinical pharmacy, First Affiliated hospital of Kunming Medical University, Yunnan, China.
Xi WangDepartment of Clinical pharmacy, First Affiliated hospital of Kunming Medical University, Yunnan, China.
Qian LiDepartment of Clinical pharmacy, First Affiliated hospital of Kunming Medical University, Yunnan, China.
Hua HuangDepartment of Clinical pharmacy, First Affiliated hospital of Kunming Medical University, Yunnan, China.
Qiao-Ling ZhengDepartment of Clinical pharmacy, First Affiliated hospital of Kunming Medical University, Yunnan, China.
Qin YaoDepartment of Clinical pharmacy, First Affiliated hospital of Kunming Medical University, Yunnan, China.
Jun ZhangDepartment of Clinical pharmacy, First Affiliated hospital of Kunming Medical University, Yunnan, China. zhangjun_pharmacy@163.com.
First Affiliated Hospital of Kunming Medical University · CNKunming Medical University · CN

Funding

National Natural Science Foundation of China 82160297Yunnan Provincial Department of Science and Technology-Kunming Medical University Joint Special Funds for Applied Basic Research Project 2019FE001 (-208)Yunnan Provincial Department of Science and Technology-Kunming Medical University Joint Special Funds for Applied Basic Research Project 202001AY070001-045Yunnan Provincial Department of Science and Technology-Kunming Medical University Joint Special Funds for Applied Basic Research Project 202101AY070001-090Yunnan Provincial Department of Science and Technology-Kunming Medical University Joint Special Funds for Applied Basic Research Project 202101AY070001-092Yunnan Provincial High-Level Health and Family Planning Technical Talent Training Special Funds Grant H-2017050Yunnan Provincial High-Level Health and Family Planning Technical Talent Training Special Funds Grant H-2017051Yunnan Provincial High-Level Health and Family Planning Technical Talent Training Special Funds Grant H-2017053
6 · The paper itself

Abstract

objectiveGestational diabetes mellitus (GDM) is a serious complication in pregnancy. Despite controlling the plasma glucose levels with dietary intervention (GDM-D) or insulin therapy (GDM-I), children born of diabetic mothers suffer more long-term complications from childhood to early adulthood. Placental circulation and nutrient exchange play a vital role in fetal development. Additionally, placental endothelial function is an indicator of vascular health, and plays an important role in maintaining placental circulation for nutrient exchange. This study was conducted to assess changes in fetal endothelial dysfunction in GDM under different interventions during pregnancy.

methodsThe primary human umbilical vein endothelial cells (HUVECs) were obtained from normal pregnant women (n = 11), GDM-D (n = 14), and GDM-I (n = 12) patients. LC-MS/MS was used to identify differentially expressed proteins in primary HUVECs among the three groups, after which Bioinformatics analysis was performed. Glucose uptake, ATP level, apoptosis, and differentially expressed proteins were assessed to investigate changes in energy metabolism.

resultsA total of 8174 quantifiable proteins were detected, and 142 differentially expressed proteins were identified after comparing patients with GDM-D/GDM-I and healthy controls. Of the 142, 64 proteins were upregulated while 77 were downregulated. Bioinformatics analysis revealed that the differentially expressed proteins were involved in multiple biological processes and signaling pathways related to cellular processes, biological regulation, and metabolic processes. According to the results from KEGG analysis, there were changes in the PI3K/AKT signaling pathway after comparing the three groups. In addition, there was a decrease in glucose uptake in the GDM-I (P < 0.01) group. In GDM-I, there was a significant decrease in the levels of glucose transporter 1 (GLUT1) and glucose transporter 3 (GLUT3). Moreover, glucose uptake was significantly decreased in GDM-I, although in GDM-D, there was only a decrease in the levels of GLUT1. ATP levels decreased in GDM-I (P < 0.05) and apoptosis occurred in both the GDM-D and GDM-I groups. Compared to the normal controls, the levels of phosphate AKT and phosphate AMPK over total AKT and AMPK were reduced in the GDM-I group.

conclusionIn summary, endothelial dysfunction occurred in pregnancies with GDM even though the plasma glucose levels were controlled, and this dysfunction might be related to the degree of glucose tolerance. The energy dysfunction might be related to the regulation of the AKT/AMPK/mTOR signaling pathway.

Indexed as

Diabetes, GestationalEndotheliumPlacentaAdenosine TriphosphateAdultAMP-Activated Protein KinasesBlood GlucoseChromatography, LiquidFemaleGlucose Transporter Type 1HumansHuman Umbilical Vein Endothelial CellsInsulinPhosphatidylinositol 3-KinasesPregnancyProto-Oncogene Proteins c-aktAdenosine TriphosphateAMP-Activated Protein KinasesBlood GlucoseGlucose Transporter Type 1InsulinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktEndothelial dysfunctionFeto-placentalGestational Diabetes MellitusGlucose transporters

Identifiers

PMID36814227
PMCPMC9948408
OpenAlexW4321486719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.